article thumbnail

LENZ Therapeutics’ Presbyopia Treatment VIZZ Receives FDA Approval in the U.S.

PharmExec

Author(s): Nicholas Jacobus Key Takeaways Vizz, an aceclidine-based eye drop, is FDA-approved for presbyopia, enhancing near vision without myopic shifts. SHOW MORE LENZ Therapeutics celebrates FDA approval of Vizz, the first aceclidine eye drop for presbyopia. I want to thank each of them for their role in getting Vizz FDA approved.”

FDA
article thumbnail

Can you drink on venlafaxine?

The Checkup by Singlecare

Though some people might be tempted to have a drink at a wedding or during dinner with friends, the medication label clearly advises against it. Food and Drug Administration (FDA) to treat major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder. Its specifically approved by the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

Pharmacy Times

SHOW MORE The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management practices. 4 By integrating FDA's new labeling requirements and CDC's framework into daily practice, pharmacists can significantly lessen opioid risk. REFERENCES 1.

article thumbnail

What are the side effects of atorvastatin for older adults?

The Checkup by Singlecare

Food and Drug Administrations (FDA) drug recall page. Take note of black box warnings Its important to note that atorvastatin (and other statins) do have a black box warning: The FDA associated statin use with cognitive impairment. Arthralgia (joint stiffness) and joint pain 6.9% Diarrhea 6.8% Dyspepsia (indigestion) 4.7%

article thumbnail

FDA Mandates Safety Alterations to Opioid Pain Medication Labels

PharmExec

New labels will include study summaries, improved dosage warnings, and information on overdose reversal agents to enhance patient and healthcare professional awareness. The FDA mandates randomized clinical trials to assess long-term opioid use benefits and risks, ensuring timely and efficient completion.

article thumbnail

FDA Addresses Opioid Medication Safety With Additional Label Changes

Drug Topics

The FDA will now require additional safety label changes to all opioid medications, including the risks associated with long-term use. 1 The FDA also calls for a scheduling action for 7-hydroxymitragynine (7-OH), with data showing the drug binds to opioid receptors.

article thumbnail

Our 2025 Medication Calculations Quiz

OctariusRx

In this post we discuss our most recent medication calculation quiz and how it can be used as a component to increase patient safety and enhance regulatory compliance. Food and Drug Administration (FDA) receives more than 100,000 reports associated with a suspected medication error. Each year, the U.S.